Editorial: Mitigating the risk of severe hepatitis flare following nucleoside analogue discontinuation-Insights from a real-world study. Authors' reply.
Saved in:
| Title: | Editorial: Mitigating the risk of severe hepatitis flare following nucleoside analogue discontinuation-Insights from a real-world study. Authors' reply. |
|---|---|
| Authors: | Hsu YC; Center for Liver Diseases, E-Da Hospital, Kaohsiung, Taiwan.; School of Medicine, I-Shou University, Kaohsiung, Taiwan.; Institute of Biomedical Informatics, National Yang Ming Chiao Tung University, Taipei, Taiwan., Wu CY; Institute of Biomedical Informatics, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Division of Translational Research, Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan. |
| Source: | Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Sep; Vol. 58 (5), pp. 550-551. |
| Publication Type: | Editorial; Comment |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2036 |
|---|---|
| DOI: | 10.1111/apt.17644 |
